{
    "code": 0,
    "data": [
        {
            "co_code": 12420,
            "bse_code": 531349,
            "isin": "INE922B01023",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Please find enclosed herewith newspaper copies of the Extract of Statement of Unaudited Financial Results for quarter and nine months ended 31.12.2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1a085d3c-7f82-48ef-8a51-5bb86aaaf378.pdf",
            "news_date": "2026-02-12 15:50:23"
        },
        {
            "sym": "PANACEABIO",
            "disp": "Panacea Biotec",
            "bse_code": 531349,
            "isin": "INE922B01023",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Standalone And Consolidated Unaudited Financial Results (Provisional) Along With Limited Review Report For The Quarter And Nine Months Ended December 31 2025",
            "news_body": "We would like to inform you that the Board of Directors has in its meeting held today i.e. 11.02.2026 inter-alia considered and approved the Standalone and Consolidated Unaudited Financial Results of the Company for the quarter and nine months ended 31.12.2025. The same was also reviewed by the Audit Committee in its meeting held today. A copy of the said financial results along with Limited Review Report is enclosed herewith.",
            "news_id": "7d38381d-f9ff-4a6d-b096-cbb1a94621b0",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1ca9ac6e-5776-4f30-81c2-d3ab97427844.pdf",
            "news_date": "2026-02-11 19:57:30",
            "seo": "panacea-biotec-ltd",
            "ltp": 354.6,
            "ch": -19.849999999999966,
            "pch": -5.301108292161828,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4055,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 12420,
            "bse_code": 531349,
            "isin": "INE922B01023",
            "ann_type": "Outcome",
            "descriptor": "Financial Results",
            "caption": "Standalone And Consolidated Unaudited Financial Results (Provisional) Along With Limited Review Report For The Quarter And Nine Months Ended December 31 2025",
            "news_body": "We would like to inform you that the Board of Directors has in its meeting held today i.e. 11.02.2026 inter-alia considered and approved the Standalone and Consolidated Unaudited Financial Results of the Company for the quarter and nine months ended 31.12.2025. The same was also reviewed by the Audit Committee in its meeting held today. A copy of the said financial results along with Limited Review Report is enclosed herewith.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1ca9ac6e-5776-4f30-81c2-d3ab97427844.pdf",
            "news_date": "2026-02-11 19:57:30"
        },
        {
            "co_code": 12420,
            "bse_code": 531349,
            "isin": "INE922B01023",
            "ann_type": "Outcome",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for Standalone And Consolidated Unaudited Financial Results (Provisional) Along With Limited Review Report For The Quarter And Nine Months Ended December 31 2025",
            "news_body": "We would like to inform you that the Board of Directors has at its meeting held today i.e. February 11 2026 inter-alia considered and approved the Standalone and Consolidated Unaudited Financial Results of the Company (which have been subjected to Limited Review by the Statutory Auditors) for the quarter and nine months ended December 31 2025. The same was also reviewed by the Audit Committee in its meeting held on Wednesday February 11 2026. A copy of the said statements of financial results along with the Limited Review Report is enclosed herewith.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d9276b31-b84b-4123-bd71-7a3ca361f177.pdf",
            "news_date": "2026-02-11 19:50:36"
        },
        {
            "co_code": 12420,
            "bse_code": 531349,
            "isin": "INE922B01023",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Details Of Shares Dematerialized During January 2026\r\nUnder Regulation 74(5) Of The SEBI (Depositories And Participants) Regulations 2018",
            "news_body": "Please find enclosed details of shares dematerialised during January 2026 under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations 2018",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=75b00984-2d45-4c4a-aa40-5adeb702d0bc.pdf",
            "news_date": "2026-02-06 15:32:14"
        },
        {
            "co_code": 12420,
            "bse_code": 531349,
            "isin": "INE922B01023",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Outcome Of Inspection By National Centre For Public Health And Pharmacy Hungary At Manufacturing Facility Of Panacea Biotec Pharma Limited At Baddi Himachal Pradesh",
            "news_body": "Please find attached outcome of inspection by National Centre for Public Health and Pharmacy Hungary at manufacturing facility of the Companys material wholly owned subsidiary Panacea Biotec Pharma Ltd. at Baddi Himachal Pradesh",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2b32b151-203e-4c0d-abd7-92b4036275c0.pdf",
            "news_date": "2026-02-05 14:52:44"
        },
        {
            "co_code": 12420,
            "bse_code": 531349,
            "isin": "INE922B01023",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Approval Of Standalone And Consolidated Unaudited Financial Results (Provisional) For The Quarter And Nine Months Ended December 31 2025",
            "news_body": "Panacea Biotec Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/02/2026 inter alia to consider and approve Standalone and Consolidated Unaudited Financial Results (Provisional) for the quarter and nine months ended December 31 2025.\r\n\r\nThe trading window of the Company shall remain closed for all Designated Persons (including their Immediate relatives) of the Company till February 13 2026",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=dae0927f-1cc3-4977-8721-1222b7a6d617.pdf",
            "news_date": "2026-02-02 15:42:35"
        },
        {
            "co_code": 12420,
            "bse_code": 531349,
            "isin": "INE922B01023",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015",
            "news_body": "We are now delighted to inform you that enrolment of study participants in context of DengiAll Phase-III clinical trial has been completed. \r\n\r\n",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fa5c8379-0b2e-434a-84b3-abcef1f1e7cd.pdf",
            "news_date": "2026-01-07 18:36:46"
        },
        {
            "co_code": 12420,
            "bse_code": 531349,
            "isin": "INE922B01023",
            "ann_type": "General_Announcements",
            "descriptor": "Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "news_body": "Please find enclosed certificate dated January 02 2026 issued by Skyline Financial Services Pvt. Ltd.  Registrar and Transfer Agent of the Company confirming compliance under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations 2018 for the quarter ended December 31 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=acc171e8-e6cb-4fed-994c-b9e08c2d1c5c.pdf",
            "news_date": "2026-01-07 16:49:18"
        },
        {
            "co_code": 12420,
            "bse_code": 531349,
            "isin": "INE922B01023",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Details Of Shares Dematerialized During December 2025\r\nUnder Regulation 74(5) Of The SEBI (Depositories And Participants) Regulations 2018",
            "news_body": "Please find the details of shares dematerialised during December 2025 under Regulation 74(5) of the SEBI  (Depositories and Participants) Regulations 2018",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b2de1f09-57cf-437f-87a9-40d0c179d28f.pdf",
            "news_date": "2026-01-07 16:45:59"
        },
        {
            "co_code": 12420,
            "bse_code": 531349,
            "isin": "INE922B01023",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Intimation Regarding Receipt Of Demand Order",
            "news_body": "Please find attached disclosure regarding receipt of Demand Orders under Section 156 of the Income Tax Act.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=36548bdd-581e-48c7-815d-2d8d465d1a37.pdf",
            "news_date": "2025-12-26 18:10:36"
        },
        {
            "co_code": 12420,
            "bse_code": 531349,
            "isin": "INE922B01023",
            "ann_type": "Intimation",
            "descriptor": "Closure of Trading Window",
            "caption": "Closure of Trading Window",
            "news_body": "We would like to inform you that the trading window of the Company shall remain closed for all Designated Persons (including their immediate relatives) of the Company from January 01 2026 till completion of 48 hours  from the announcement of unaudited financial results of the Company for the quarter and nine months ending December 31 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0a83b9e1-3f98-417b-b790-0a8f40e10e55.pdf",
            "news_date": "2025-12-26 17:54:48"
        },
        {
            "co_code": 12420,
            "bse_code": 531349,
            "isin": "INE922B01023",
            "ann_type": "General_Announcements",
            "descriptor": "Award of Order / Receipt of Order",
            "caption": "Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order",
            "news_body": "We are delighted to inform you about the receipt of an amended Award from UNICEF for supply of Pentavalent vaccine Easyfive-TT",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c48cb670-5889-46b6-acb6-f11958a0ffc6.pdf",
            "news_date": "2025-12-24 17:09:32"
        },
        {
            "co_code": 12420,
            "bse_code": 531349,
            "isin": "INE922B01023",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Authorization Of Key Managerial Personnel For The Purpose Of Determining Materiality Of An Event Or Information &Making Disclosures To The Stock Exchange(S) Under The SEBI LODR Regulations",
            "news_body": "We would like to inform you that the Board of Directors in its meeting held today i.e. December 15 2025 approved revised Policy for determining Materiality of Events / Information and authorised few Key Managerial Personnel for the purpose of determining materiality of an event or information & making disclosures to stock exchanges under the SEBI LODR Regulations.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f3888c1b-07fb-4bd6-a61d-9d60b09c9948.pdf",
            "news_date": "2025-12-15 18:54:56"
        },
        {
            "co_code": 12420,
            "bse_code": 531349,
            "isin": "INE922B01023",
            "ann_type": "General_Announcements",
            "descriptor": "Appointment of Company Secretary / Compliance Officer",
            "caption": "Appointment of Company Secretary and Compliance Officer",
            "news_body": "We would like to inform you that Mr. Ankit Jain (who is currently acting as Assistant General Manager - Legal of the Companys wholly owned subsidiary Panacea Biotec Pharma Ltd.) has been appointed as Company Secretary and Compliance Officer designated as General Manager - Legal & Company Secretary of the Company under the category of KMP and SMP with effect from December 16 2025 based on the recommendation and approval of the Nomination & Remuneration Committee.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8e113096-68c8-4de0-bbb0-faefa33860aa.pdf",
            "news_date": "2025-12-15 18:43:38"
        },
        {
            "co_code": 12420,
            "bse_code": 531349,
            "isin": "INE922B01023",
            "ann_type": "General_Announcements",
            "descriptor": "Cessation",
            "caption": "Announcement under Regulation 30 (LODR)-Cessation",
            "news_body": "We would like to inform you that Mr. Vinod Goel (who is currently acting as Group CFO and Head Legal & Company Secretary as well as Compliance Officer of the Company) shall cease to be Company Secretary and Compliance Officer of the Company w.e.f. December 15 2025 consequent to his appointment as Chief Financial Officer and Head Legal & Corporate Governance of the Company w.e.f. December 16 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bcb4f156-6093-435f-a543-4bd060049505.pdf",
            "news_date": "2025-12-15 18:38:48"
        },
        {
            "co_code": 12420,
            "bse_code": 531349,
            "isin": "INE922B01023",
            "ann_type": "General_Announcements",
            "descriptor": "Change in Management",
            "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
            "news_body": "Mr. Vinod Goel (who is currently acting as Group CFO and Head Legal & Company Secretary as well as Compliance Officer of the Company) has been appointed as Chief Financial Officer under the category of KMP and SMP designated as Group Chief Financial Officer and Head Legal & Corporate Governance of the Company with effect from December 16 2025 based on the recommendation and approval of the Nomination & Remuneration Committee and Audit Committee.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bd8dc453-3b23-43a0-ae47-0814bf03bf45.pdf",
            "news_date": "2025-12-15 18:34:18"
        },
        {
            "co_code": 12420,
            "bse_code": 531349,
            "isin": "INE922B01023",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Details Of Shares Dematerialized During November 2025\r\nUnder Regulation 74(5) Of The SEBI (Depositories And Participants) Regulations 2018",
            "news_body": "Please enclosed herewith the details of shares dematerialised during November 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ba0ccf87-cb78-460f-98bb-34ddbaf7bb5a.pdf",
            "news_date": "2025-12-04 15:11:02"
        },
        {
            "co_code": 12420,
            "bse_code": 531349,
            "isin": "INE922B01023",
            "ann_type": "General_Announcements",
            "descriptor": "Change in Management",
            "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
            "news_body": "We would like to inform you that Mr. Devender Gupta Chief Financial Officer and Head Information Technology designated as Key Managerial Personnel and Senior Management Personnel of the Company has tendered his resignation on account of personal reasons with effect from December 15 2025.\r\n\r\nThe requisite disclosure in this regard is attached herewith.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7f93d130-c616-4c87-a533-7820ac1c9c43.pdf",
            "news_date": "2025-11-26 18:08:19"
        },
        {
            "co_code": 12420,
            "bse_code": 531349,
            "isin": "INE922B01023",
            "ann_type": "General_Announcements",
            "descriptor": "Resignation of Chief Financial Officer (CFO)",
            "caption": "Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO)",
            "news_body": "We would like to inform you that Mr. Devender Gupta Chief Financial Officer and Head Information Technology designated as Key Managerial Personnel and Senior Management Personnel of the Company has tendered his resignation on account of personal reasons w.e.f. December 15 2025.\r\n\r\nThe required disclosure in this regard is attached herewith.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=39032d00-ccde-44cb-a43c-429b3af65b39.pdf",
            "news_date": "2025-11-26 18:03:55"
        },
        {
            "co_code": 12420,
            "bse_code": 531349,
            "isin": "INE922B01023",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Please find enclosed herewith newspaper copies of the Extract of Statement of Unaudited Financial Results for quarter and half year ended September 302025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6137af45-82e3-43e3-959b-36ec4e11e6ee.pdf",
            "news_date": "2025-11-15 12:56:00"
        },
        {
            "sym": "PANACEABIO",
            "disp": "Panacea Biotec",
            "bse_code": 531349,
            "isin": "INE922B01023",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Standalone And Consolidated Unaudited Financial Results (Provisional) Along With Limited Review Report For The Quarter And Half Year Ended September 30 2025",
            "news_body": "Please find enclosed herewith the Standalone and Consolidated Unaudited Financial Results of the Company for the quarter and half year ended September 30 2025. The same were also reviewed by the Audit Committee in its meeting held on November  14 2025.",
            "news_id": "f1df31f3-8398-4cc7-ab76-eb0890c67e70",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=168e22ef-d456-40bd-99ff-dc4ce5d7ddcc.pdf",
            "news_date": "2025-11-14 17:24:44",
            "seo": "panacea-biotec-ltd",
            "ltp": 354.6,
            "ch": -19.849999999999966,
            "pch": -5.301108292161828,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4055,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 12420,
            "bse_code": 531349,
            "isin": "INE922B01023",
            "ann_type": "Outcome",
            "descriptor": "Financial Results",
            "caption": "Standalone And Consolidated Unaudited Financial Results (Provisional) Along With Limited Review Report For The Quarter And Half Year Ended September 30 2025",
            "news_body": "Please find enclosed herewith the Standalone and Consolidated Unaudited Financial Results of the Company for the quarter and half year ended September 30 2025. The same were also reviewed by the Audit Committee in its meeting held on November  14 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=168e22ef-d456-40bd-99ff-dc4ce5d7ddcc.pdf",
            "news_date": "2025-11-14 17:24:44"
        },
        {
            "co_code": 12420,
            "bse_code": 531349,
            "isin": "INE922B01023",
            "ann_type": "Outcome",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for Standalone And Consolidated Unaudited Financial Results (Provisional) Along With Limited Review Report For The Quarter And Half Year Ended September 30 2025",
            "news_body": "We would like to inform you that the Board of Directors has at its meeting held today i.e. November\r\n14 2025 inter-alia considered and approved the Standalone and Consolidated Unaudited Financial\r\nResults of the Company for the quarter and half year ended September 30 2025. The same were also reviewed by the Audit Committee in its meeting held on November 14 2025. A copy of the said results along with the Limited\r\nReview Report is enclosed herewith.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=35198ac3-afdd-4c85-9e89-c47d242eb491.pdf",
            "news_date": "2025-11-14 17:17:58"
        },
        {
            "co_code": 12420,
            "bse_code": 531349,
            "isin": "INE922B01023",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Intimation Regarding Change In Senior Management Personnel In The CompanyS Material Wholly Owned Subsidiary Viz. Panacea Biotec Pharma Limited (PBPL)",
            "news_body": "We would like to inform you that Mr. Bal Krishan Saini Sr. Vice President - Head Pharma Plant Operation & Corporate Project and Engineering Head has been designated as the Senior Management Personnel of PBPL w.e.f. 13.11.2025.\r\n\r\nThe requisite disclosure in this regard is attached herewith.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ef0f906a-7568-46f0-881e-2b99b0f2def5.pdf",
            "news_date": "2025-11-13 18:11:02"
        },
        {
            "co_code": 12420,
            "bse_code": 531349,
            "isin": "INE922B01023",
            "ann_type": "General_Announcements",
            "descriptor": "Award of Order / Receipt of Order",
            "caption": "Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order",
            "news_body": "We are delighted to inform you that the Company has received an Award notification from PAHO under a Long-Term Agreement for supply of Easyfive-TT to PAHO aggregating ~US$4.75 million (Rs.41 Crore) during Calendar Year 2026 and 2027.\r\n\r\nThe requisite details as required under SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 is attached herewith.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a0c6e9bf-f172-4d67-ade8-1331f14dc24e.pdf",
            "news_date": "2025-11-11 16:56:06"
        },
        {
            "co_code": 12420,
            "bse_code": 531349,
            "isin": "INE922B01023",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Details Of Shares Dematerialized During October 2025\r\nUnder Regulation 74(5) Of The SEBI (Depositories And Participants) Regulations 2018",
            "news_body": "Please find attached details of shares dematerialised during October 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=939dc927-9c23-4637-9f5a-1743a485dfac.pdf",
            "news_date": "2025-11-07 17:48:39"
        },
        {
            "co_code": 12420,
            "bse_code": 531349,
            "isin": "INE922B01023",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015",
            "news_body": "In continuation to our earlier letter dated July 01 2024 we would like to inform you that the Company has filed its Statement of Defense and Counterclaims in response to the Statement of Case filed by Human Vaccine Limited Liability Company on November 06 2025.\r\n\r\nThe requisite disclosure in this regard is attached herewith.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f6f1326e-913d-457e-9b1b-37e7f3a8dbf8.pdf",
            "news_date": "2025-11-06 16:40:35"
        },
        {
            "co_code": 12420,
            "bse_code": 531349,
            "isin": "INE922B01023",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Approving Standalone And Consolidated Unaudited Financial Results (Provisional) For The Quarter And Half Year Ended September 30 2025",
            "news_body": "Panacea Biotec Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2025 inter alia to consider and approve the Standalone and Consolidated Unaudited Financial Results (Provisional) for the quarter and half year ended September 30 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3de787f9-030f-43df-a8ba-5d4d92a852d0.pdf",
            "news_date": "2025-11-04 17:29:18"
        },
        {
            "co_code": 12420,
            "bse_code": 531349,
            "isin": "INE922B01023",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Please find attached newspaper copies regarding Notice intimating the shareholders about the opening of a Special Window for Re-lodgement of transfer requests of physical shares",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=dabc74e6-34cc-41c8-bb4b-cb311b1db623.pdf",
            "news_date": "2025-10-17 14:32:41"
        },
        {
            "co_code": 12420,
            "bse_code": 531349,
            "isin": "INE922B01023",
            "ann_type": "General_Announcements",
            "descriptor": "Award of Order / Receipt of Order",
            "caption": "Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order",
            "news_body": "We are delighted to inform you that the Central Medical Services Society Ministry of Health and Family Welfare Government of India (CMSS) has vide its Letter of Acceptance (LOA) dated October 08 2025 accepted the Companys offer for supply of bivalent oral polio vaccine (bOPV) worth Rs.127.20 Crore against the tender issued by it in this regard.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0600c17e-3699-4a97-85b1-af6f694b0a98.pdf",
            "news_date": "2025-10-09 12:18:23"
        },
        {
            "co_code": 12420,
            "bse_code": 531349,
            "isin": "INE922B01023",
            "ann_type": "General_Announcements",
            "descriptor": "Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "news_body": "Please find attached certificate issued by Skyline Financial Services Private Limited (RTA) confirming compliance under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations  2018 for the quarter ended September 30 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5921c9c2-227d-4448-8df6-364517ea2d1d.pdf",
            "news_date": "2025-10-07 17:32:59"
        },
        {
            "co_code": 12420,
            "bse_code": 531349,
            "isin": "INE922B01023",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Demat Status Report For The Month Of September 2025",
            "news_body": "Please find attached the data of shares dematerialized during the month of September 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=72e16255-c9ef-422f-ada5-dec212880f2c.pdf",
            "news_date": "2025-10-07 17:28:56"
        },
        {
            "co_code": 12420,
            "bse_code": 531349,
            "isin": "INE922B01023",
            "ann_type": "General_Announcements",
            "descriptor": "Award of Order / Receipt of Order",
            "caption": "Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order",
            "news_body": "We are delighted to inform you that the Company has received a Letter of Award from Unicef for a Long-Term Agreement for supply of bivalent oral polio vaccine (bOPV) to Unicef worth ~US$ 35.65 million (~Rs.315 Crore) for a period of Q2 CY2026 and CY2027.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ca1f2489-b9e2-4a27-8506-c33959956b16.pdf",
            "news_date": "2025-10-03 14:27:13"
        },
        {
            "co_code": 12420,
            "bse_code": 531349,
            "isin": "INE922B01023",
            "ann_type": "Outcome",
            "descriptor": "AGM",
            "caption": "Shareholder Meeting / Postal Ballot-Scrutinizers Report",
            "news_body": "Please find attached detailed voting results along with the Scrutinizers Report on the resolutions passed in the AGM held on September 30 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ab8a372f-787e-4a69-baa5-b9a8ad46f8ec.pdf",
            "news_date": "2025-10-01 17:30:29"
        },
        {
            "co_code": 12420,
            "bse_code": 531349,
            "isin": "INE922B01023",
            "ann_type": "Outcome",
            "descriptor": "AGM",
            "caption": "Shareholder Meeting / Postal Ballot-Outcome of AGM",
            "news_body": "Please find attached detailed voting results along with the Scrutinizers Report on the resolutions passed in the AGM held on September 30 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8abbb253-985c-4dcb-88b5-4b02a174487d.pdf",
            "news_date": "2025-10-01 17:25:20"
        },
        {
            "co_code": 12420,
            "bse_code": 531349,
            "isin": "INE922B01023",
            "ann_type": "General_Announcements",
            "descriptor": "AGM",
            "caption": "Proceedings Of The 41St Annual General Meeting Held On September 30 2025",
            "news_body": "Please find enclosed herewith the proceedings of the 41st Annual General Meeting of the Company held on Tuesday September 30 2025 at 11:30 A.M. through video conferencing.\r\n\r\n",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5a4e7744-6c90-441f-8214-aa856f8401c0.pdf",
            "news_date": "2025-09-30 16:40:50"
        },
        {
            "co_code": 12420,
            "bse_code": 531349,
            "isin": "INE922B01023",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Disclosure Under Regulation 30 Of SEBI LODR Regulations",
            "news_body": "Please find enclosed disclosure w.r.t. receipt of a show cause notice from the office of the Commissioner Central GST (Audit) Commissionerate Punjab under the Goods and Service Tax Act 2017 alongwith details in the prescribed format.\r\n\r\n",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=766fe439-25aa-4787-9a8a-51a4e336648d.pdf",
            "news_date": "2025-09-27 15:32:01"
        },
        {
            "co_code": 12420,
            "bse_code": 531349,
            "isin": "INE922B01023",
            "ann_type": "Intimation",
            "descriptor": "Closure of Trading Window",
            "caption": "Closure of Trading Window",
            "news_body": "We would like to inform you that the trading window of the Company shall remain closed for all Designated Persons (including their immediate relatives) of the Company from October 01 2025 till completion of 48 hours from the announcement of the Unaudited Financial Results of the Company for the quarter and half year ending September  30 2025 to the Stock Exchanges.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a91eeb52-2cbb-45e4-b69c-72ec419c2353.pdf",
            "news_date": "2025-09-26 16:14:17"
        },
        {
            "co_code": 12420,
            "bse_code": 531349,
            "isin": "INE922B01023",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Launch Of IndiaS First 100% Toxin-Free And Safe Nikomom Baby Skin Care Products And Staart Prime Infant Milk Substitute Product By CompanyS Wholly-Owned Subsidiary Panacea Biotec Pharma Limited",
            "news_body": "Please find attached stock exchange intimation regarding launch of Indias first 100% toxin-free and safe NikoMom Baby Skin Care Products and Staart Prime infant Milk Substitute Product by the Companys wholly owned subsidiary Panacea Biotec Pharma Limited.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=23c276e6-9514-41e4-bda8-23c7166b9d02.pdf",
            "news_date": "2025-09-24 18:17:02"
        },
        {
            "co_code": 12420,
            "bse_code": 531349,
            "isin": "INE922B01023",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "We are pleased to announce that the Companys wholly owned subsidiary Panacea Biotec Pharma Limited has launched Indias first 100% toxin-free and safe baby skin care products under the existing brand name \"NikoMom\".\r\n\r\nThe details of the said product is mentioned in the attached file.\r\n\r\nAlso a copy of the press release issued in this regard is attached herewith.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=72b8a84c-2015-41c6-acd9-f3f689e6c5a9.pdf",
            "news_date": "2025-09-24 18:09:19"
        },
        {
            "co_code": 12420,
            "bse_code": 531349,
            "isin": "INE922B01023",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Communication Sent To Physical Shareholders To Furnish PAN And KYC Details",
            "news_body": "Please note that the Company has sent reminder letters on September 19 2025 to the shareholders holding shares in physical mode requesting them to furnish PAN and KYC details for updation to the Company / RTA along with request to dematerialize the shares with Depository Participant.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e7aaf9eb-3855-4a0b-9342-292f3ca38e18.pdf",
            "news_date": "2025-09-19 16:41:59"
        },
        {
            "co_code": 12420,
            "bse_code": 531349,
            "isin": "INE922B01023",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Please find enclosed newspaper copies regarding advertisement of Notice of 41st Annual General Meeting Cut-off Date and Remote e-voting information published on September 09 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2b2d38fa-a842-4620-a2ff-4adaa8370ca1.pdf",
            "news_date": "2025-09-09 15:19:08"
        },
        {
            "co_code": 12420,
            "bse_code": 531349,
            "isin": "INE922B01023",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Demat Status Report For The Month Of August 2025",
            "news_body": "Please find attached demat status report for the month of August 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7723435e-988d-4f73-b4e8-dbd3376937f1.pdf",
            "news_date": "2025-09-08 17:56:40"
        },
        {
            "co_code": 12420,
            "bse_code": 531349,
            "isin": "INE922B01023",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015",
            "news_body": "We would like to inform you that pursuant to Regulation 36(1)(b) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 the enclosed letter is being sent to the shareholders whose e-mail addresses are not registered with the Company / Depository Participants providing the weblink for accessing the Annual Report of the Company for the financial year 2024-25 and the Notice of the ensuing AGM to be held on September 30 2025 through VC / OAVM",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1989ff23-da09-4059-8991-a98ff68bf65a.pdf",
            "news_date": "2025-09-08 17:43:54"
        },
        {
            "co_code": 12420,
            "bse_code": 531349,
            "isin": "INE922B01023",
            "ann_type": "General_Announcements",
            "descriptor": "Business Responsibility and Sustainability Reporting (BRSR)",
            "caption": "Business Responsibility and Sustainability Reporting (BRSR)",
            "news_body": "Please find attached Business Responsibility and Sustainability Report for financial year 2024-25",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=027ec2ea-cf2d-4587-85af-1e788d15cf2c.pdf",
            "news_date": "2025-09-08 16:37:36"
        },
        {
            "co_code": 12420,
            "bse_code": 531349,
            "isin": "INE922B01023",
            "ann_type": "General_Announcements",
            "descriptor": "Reg. 34 (1) Annual Report",
            "caption": "Reg. 34 (1) Annual Report.",
            "news_body": "Please find attached Annual Report for financial year 2024-25",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ff14212f-1b94-4900-a856-ce6759b4e6ab.pdf",
            "news_date": "2025-09-08 16:34:21"
        },
        {
            "co_code": 12420,
            "bse_code": 531349,
            "isin": "INE922B01023",
            "ann_type": "Intimation",
            "descriptor": "AGM",
            "caption": "Intimation Of 41St Annual General Meeting Of The Company To Be Held On Tuesday September 30 2025 At 11:30 A.M. (IST) Through Video Conferencing (VC) / Other Audio Visual Means (OAVM)",
            "news_body": "Please find enclosed AGM Notice and Annual Report for FY 2024-25 which is being sent to the Members through electronic mode.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1ce6d194-c331-4f7a-b74a-2357b1660547.pdf",
            "news_date": "2025-09-08 16:20:32"
        },
        {
            "co_code": 12420,
            "bse_code": 531349,
            "isin": "INE922B01023",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Please find enclosed newspaper copies of the public notice requesting shareholders to register their email addresses with the Company in connection with ensuing AGM of the Company.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=86414f40-339e-4993-9f85-73d3e5d41997.pdf",
            "news_date": "2025-08-30 17:10:04"
        },
        {
            "co_code": 12420,
            "bse_code": 531349,
            "isin": "INE922B01023",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Please find enclosed herewith newspaper copies of the Extract of Statement of Unaudited Financial Results published on August 15 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=16691eef-edbf-4326-bfeb-8aeb35cf0d03.pdf",
            "news_date": "2025-08-16 12:37:01"
        },
        {
            "sym": "PANACEABIO",
            "disp": "Panacea Biotec",
            "bse_code": 531349,
            "isin": "INE922B01023",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Standalone And Consolidated Unaudited Financial Results (Provisional) Along With Limited Review Report For The Quarter Ended 30.06.2025",
            "news_body": "Please find attached Standalone and Consolidated Unaudited Financial Results for quarter ended June 30 2025. A copy of the said results along with Limited Review Report is attached herewith",
            "news_id": "078ba840-9a52-4d76-b9bb-0416668915e7",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ae14fd81-cc46-4e60-903b-65a3c8bd21f2.pdf",
            "news_date": "2025-08-14 18:25:08",
            "seo": "panacea-biotec-ltd",
            "ltp": 354.6,
            "ch": -19.849999999999966,
            "pch": -5.301108292161828,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4055,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 12420,
            "bse_code": 531349,
            "isin": "INE922B01023",
            "ann_type": "Outcome",
            "descriptor": "Financial Results",
            "caption": "Standalone And Consolidated Unaudited Financial Results (Provisional) Along With Limited Review Report For The Quarter Ended 30.06.2025",
            "news_body": "Please find attached Standalone and Consolidated Unaudited Financial Results for quarter ended June 30 2025. A copy of the said results along with Limited Review Report is attached herewith",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ae14fd81-cc46-4e60-903b-65a3c8bd21f2.pdf",
            "news_date": "2025-08-14 18:25:08"
        },
        {
            "co_code": 12420,
            "bse_code": 531349,
            "isin": "INE922B01023",
            "ann_type": "Outcome",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held On August 14 2025",
            "news_body": "The Board has considered and approved the Standalone and Consolidated Unaudited Financial Results of the Company for the quarter ended June 30 2025. The same was also reviewed by the Audit Committee in its meeting held on August 13 2025. A copy of the said results along with the Limited Review\r\nReport is enclosed herewith.\r\n\r\n",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=00c9b379-d052-49db-a883-60843bb1e82b.pdf",
            "news_date": "2025-08-14 17:41:10"
        },
        {
            "co_code": 12420,
            "bse_code": 531349,
            "isin": "INE922B01023",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Demat Status Report For The Month Of July 2025",
            "news_body": "Please find attached details of shares dematerialised during July 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=220301fd-4887-4c3e-ac3b-ff4082be1a50.pdf",
            "news_date": "2025-08-07 16:46:41"
        },
        {
            "co_code": 12420,
            "bse_code": 531349,
            "isin": "INE922B01023",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Approval Of Standalone And Consolidated Unaudited Financial Results (Provisional) For The Quarter Ended June 30 2025",
            "news_body": "Panacea Biotec Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2025 inter alia to consider and approve Standalone and Consolidated Unaudited Financial Results (Provisional) for the quarter ended June 30 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=22bf55ee-6c62-4c51-bbd7-1dba10a9b67b.pdf",
            "news_date": "2025-08-04 18:08:47"
        },
        {
            "co_code": 12420,
            "bse_code": 531349,
            "isin": "INE922B01023",
            "ann_type": "General_Announcements",
            "descriptor": "Change in Management",
            "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
            "news_body": "We would like to inform you that Mr. Mohammed Shafiqur Rahman has ceased to be the Senior Management Personnel of the Company with effect from close of business hours on 31.07.2025 due to superannuation.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3da1e2cf-9022-4092-a505-166143949321.pdf",
            "news_date": "2025-07-31 20:18:15"
        },
        {
            "co_code": 12420,
            "bse_code": 531349,
            "isin": "INE922B01023",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Intimation Under Regulation 30 And Regulation 31A(8) Of The Securities & Exchange Board Of India (Listing Obligations & Disclosure Requirements) Regulations 2015  - Approval For Reclassification Of Mrs. Sunanda Jain Mr. Sumit Jain And Ms. Radhika Jain Fro",
            "news_body": "We are pleased to inform that the Company has received on July 29 2025 the requisite approval from BSE and NSE for reclassification from \"Promoter and Promoters Group\" category to the \"Public\" category of  shareholders of the Company in accordance with provisions of Regulation 31A(3) of the SEBI (LODR) Regulations 2015.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9cf084b8-d66a-4f8e-85bb-f1dc1f4e59fa.pdf",
            "news_date": "2025-07-29 17:43:29"
        },
        {
            "co_code": 12420,
            "bse_code": 531349,
            "isin": "INE922B01023",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Please find enclosed herewith newspaper copies regarding Notice intimating the shareholders about the opening of a Special Window for Re-lodgement of transfer requests of physical shares in accordance with SEBI Circular No. SEBI/HO/MIRSD-PoD/P/CIR/2025/97 dated July 02 2025 published on July 19 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=edafb326-79e6-45eb-95e4-02f650a7bf3c.pdf",
            "news_date": "2025-07-19 15:18:25"
        },
        {
            "co_code": 12420,
            "bse_code": 531349,
            "isin": "INE922B01023",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015",
            "news_body": "In connection with our earlier letter dated August 20 2024 please find attached Demand Order dated 10.07.2025 from the office of the Assistant Commissioner of State tax GST Bhawan Mazgon Mumbai.\r\n\r\n",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4c086f75-c50f-4ee7-be8d-d2d54ba3893b.pdf",
            "news_date": "2025-07-11 16:52:24"
        },
        {
            "co_code": 12420,
            "bse_code": 531349,
            "isin": "INE922B01023",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Intimation Of Settlement Of Disputes With Apotex Inc. Canada\r\nUnder Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015",
            "news_body": "We are pleased to inform you that the parties have executed a Settlement Agreement on July 09 2025 recording full and final settlement of the disputes forming part of the arbitration among Apotex Inc. the Company and its wholly owned subsidiary Panacea Biotec Pharma Ltd.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f129f7a8-5ade-4774-9f02-2b7c651b59eb.pdf",
            "news_date": "2025-07-09 15:19:34"
        },
        {
            "co_code": 12420,
            "bse_code": 531349,
            "isin": "INE922B01023",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Details Of Shares Dematerialised During June 2025 Under  Regulation 74(5) Of The SEBI (Depositories And Participants) Regulations 2018",
            "news_body": "We would like to inform you that no share has been dematerialised during the month of June 2025. \r\n\r\nA copy of the certificate from the Companys RTA viz. Skyline Financial Services Pvt. Ltd. regarding shares dematerialised as on June 30 2025 is enclosed herewith.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d7ee85c3-2a28-4ab1-b23a-0d8f5503ff74.pdf",
            "news_date": "2025-07-07 16:44:13"
        },
        {
            "co_code": 12420,
            "bse_code": 531349,
            "isin": "INE922B01023",
            "ann_type": "General_Announcements",
            "descriptor": "Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "news_body": "We are enclosing a certificate dated July 02 2025 issued by Skyline Financial Services Private Limited Registrar and Transfer Agent of the Company confirming compliance under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations 2018 for the quarter ended June 30 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ee18aa5a-ee2b-42f9-9292-2a972a281b4d.pdf",
            "news_date": "2025-07-07 16:40:14"
        },
        {
            "co_code": 12420,
            "bse_code": 531349,
            "isin": "INE922B01023",
            "ann_type": "Intimation",
            "descriptor": "Closure of Trading Window",
            "caption": "Closure of Trading Window",
            "news_body": "We would like to inform that the trading window of the Company shall remain closed for all the Designated Persons (including their immediate relatives) of the Company from July 01 2025 till completion of 48 hours from the announcement of the Unaudited financial results of the Company for the quarter ending June 30 2025 to the Stock Exchanges.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=336cbf43-bfe7-487a-b291-2dd1b79573fc.pdf",
            "news_date": "2025-06-26 17:18:54"
        },
        {
            "co_code": 12420,
            "bse_code": 531349,
            "isin": "INE922B01023",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Details Of Shares Dematerialised During May 2025 Under Regulation 74(5) Of The SEBI (Depositories And Participants) Regulations 2018",
            "news_body": "We are enclosing herewith the details of shares dematerialised during the month of May 2025. A copy of the certificate obtained from RTA in this regard is also attached herewith.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b6ac6cec-aa94-4c82-922b-24977aed002f.pdf",
            "news_date": "2025-06-06 15:46:21"
        },
        {
            "co_code": 12420,
            "bse_code": 531349,
            "isin": "INE922B01023",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Please find attached Press Release regarding inclusion of EmulsiPan adjuvant in the CEPI Adjuvant Library and its foray into commercialisation of its indigenously developed adjuvants",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9603affa-32a2-4f1c-88a8-d7114640cc0d.pdf",
            "news_date": "2025-06-03 11:19:52"
        },
        {
            "co_code": 12420,
            "bse_code": 531349,
            "isin": "INE922B01023",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Please find attached newspaper copies of the Extract of Statement of Audited Standalone and Consolidated Financial Results of the Company for the quarter and financial year ended March 31 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f86c3639-ae98-4b11-a4ba-d0e3bbbe6703.pdf",
            "news_date": "2025-05-31 15:30:06"
        },
        {
            "co_code": 12420,
            "bse_code": 531349,
            "isin": "INE922B01023",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Intimation Regarding Appointment Of Secretarial Auditor",
            "news_body": "M/s R&D Company Secretaries have been appointed as Secretarial Auditors for a period of 5 consecutive years commencing from FY 2025-26 to FY 2029-30",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=09402f3b-135f-4a78-aafd-b8d98af8f855.pdf",
            "news_date": "2025-05-30 20:37:19"
        },
        {
            "co_code": 12420,
            "bse_code": 531349,
            "isin": "INE922B01023",
            "ann_type": "Compliance",
            "descriptor": "Reg.24(A)-Annual Secretarial Compliance",
            "caption": "Compliances-Reg.24(A)-Annual Secretarial Compliance",
            "news_body": "Please find attached Annual Secretarial Compliance Report for FY 2024-25",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=be96617f-afe3-48df-875d-bf56d84856ae.pdf",
            "news_date": "2025-05-30 20:24:59"
        },
        {
            "sym": "PANACEABIO",
            "disp": "Panacea Biotec",
            "bse_code": 531349,
            "isin": "INE922B01023",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Standalone And Consolidated Audited Financial Results Along With Auditors Report For The Quarter And Financial Year Ended March 31 2025",
            "news_body": "The Standalone and Consolidated financial results for quarter and financial year ended March 31 2025 is attached herewith.",
            "news_id": "fdb3b753-36d9-4fee-903d-45a51a60d8f1",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c9c2b03f-7688-4c0e-8880-188d6b327f8c.pdf",
            "news_date": "2025-05-30 20:22:16",
            "seo": "panacea-biotec-ltd",
            "ltp": 354.6,
            "ch": -19.849999999999966,
            "pch": -5.301108292161828,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4055,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 12420,
            "bse_code": 531349,
            "isin": "INE922B01023",
            "ann_type": "Outcome",
            "descriptor": "Financial Results",
            "caption": "Standalone And Consolidated Audited Financial Results Along With Auditors Report For The Quarter And Financial Year Ended March 31 2025",
            "news_body": "The Standalone and Consolidated financial results for quarter and financial year ended March 31 2025 is attached herewith.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c9c2b03f-7688-4c0e-8880-188d6b327f8c.pdf",
            "news_date": "2025-05-30 20:22:16"
        },
        {
            "co_code": 12420,
            "bse_code": 531349,
            "isin": "INE922B01023",
            "ann_type": "Outcome",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for 1. Standalone And Consolidated Audited Financial Results Along With Auditors Report For The Quarter And Financial Year Ended March 31 2025\r\n   2. Passing Over Of Dividend For The Financial Year 2024-25\r\n3. Appointment Of Secretar",
            "news_body": "Please find attached Outcome of Board Meeting held on May 30 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=acd832df-2cd3-4e99-8df5-0664fc034d45.pdf",
            "news_date": "2025-05-30 20:06:23"
        },
        {
            "co_code": 12420,
            "bse_code": 531349,
            "isin": "INE922B01023",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for For Approval Of The Audited Financial Results For The Quarter And Financial Year Ended March 31 2025 And Passing Over Of Dividend On Equity As Well As Preference Shares For The Said Financial Year.",
            "news_body": "Panacea Biotec Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2025 inter alia to consider and approve the Audited Financial Results for the Quarter and Financial Year ended March 31 2025 and passing over of dividend on equity as well as preference shares for the said Financial Year",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=40330699-f3f9-49c7-95b9-0253b2bff219.pdf",
            "news_date": "2025-05-24 15:36:27"
        },
        {
            "co_code": 12420,
            "bse_code": 531349,
            "isin": "INE922B01023",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Nation-Wide Study Undertaken By Panacea Biotec Pharma Ltd. (Material WOS) Confirms Chilrun Full Accelerates Growth And Development In Children",
            "news_body": "A copy of the Nation-Wide Study undertaken by Panacea Biotec Pharma Ltd. (material WOS) confirms ChilRun full Accelerates Growth and Development in Children in just 90 days is enclosed herewith.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=56027ab6-4c17-4d2f-a8f6-9893cc33675d.pdf",
            "news_date": "2025-05-19 17:48:57"
        },
        {
            "co_code": 12420,
            "bse_code": 531349,
            "isin": "INE922B01023",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Details Of Shares Dematerialized During April 2025 Under Regulation 74(5) Of The SEBI (Depositories And Participants) Regulations 2018",
            "news_body": "Please find attached details of shares dematerialised during April 2025 under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations 2018",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=57832dd1-a37b-4d80-9145-6c1995b18ef1.pdf",
            "news_date": "2025-05-06 16:48:33"
        },
        {
            "co_code": 12420,
            "bse_code": 531349,
            "isin": "INE922B01023",
            "ann_type": "Compliance",
            "descriptor": "Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure ",
            "caption": "Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A",
            "news_body": "  <b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=1px><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> </tr> <tr><td>1</td><td>Name of Company</td><td>Panacea Biotec Ltd</td></tr> <tr><td>2</td><td>CIN NO.</td><td>L33117PB1984PLC022350</td></tr> <tr><td>3</td> <td>Outstanding borrowing of company as on 31st March / 31st December as applicable (in Rs cr)</td> <td>15.00</td></tr> <tr><td>4</td><td>Highest Credit Rating during the previous FY </td><td>NA</td></tr> <tr><td>4a</td><td>Name of the Credit Rating Agency issuing the Credit Rating mentioned in (4)</td><td>Not Applicable</td></tr> <tr><td>5</td><td>Name of Stock Exchange# in which the fine shall be paid in case of shortfall in the required borrowing under the framework</td><td>BSE</td></tr> </table>  <br/><br/> <div> <div style=float:left;> We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26 2018. No</div> <br/><br/><br/> <div style=float:left;> Name of the Company Secretary: Vinod Goel <br/>  Designation: Group CFO and Head Legal and Company Secretary <br/> EmailId: vinodgoel@panaceabiotec.com</div> <div style=float:left;margin-left:50px;> Name of the Chief Financial Officer: Devender Gupta <br/> Designation: CFO and Head Information Technology <br/> EmailId: devendergupta@panaceabiotec.com</div> </div> <div> <br/> Date: 29/04/2025<br/><br/> <b>Note:<b> In terms para of 3.2(ii) of the circular beginning F.Y 2022 in the event of shortfall in the mandatory borrowing through debt securities a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore an entity identified as LC shall provide in its initial disclosure for a financial year the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets. </div>",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5548ccbf-acbc-4527-af7c-03862e5acf36.pdf",
            "news_date": "2025-04-29 17:18:46"
        },
        {
            "co_code": 12420,
            "bse_code": 531349,
            "isin": "INE922B01023",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Receipt Of An Additional Award From UNICEF For Supply Of Bivalent Oral Polio Vaccine (Bopv) Worth ~US$ 5.20 Million In Q3 CY2025",
            "news_body": "We are delighted to inform you that Panacea Biotec Ltd. has received an additional Award from UNICEF for supply of 40 million doses of its bivalent oral polio vaccine (bOPV) worth ~US$ 5.20 million (~Rs.44 Crore) in Q3 CY2025.\r\n\r\nThe details with respect to the said Award in the specified format as per the SEBI Circular dated July 13 2023 is annexed herewith.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cc2894fd-6033-4041-b347-ba3e949f2af8.pdf",
            "news_date": "2025-04-23 15:30:16"
        },
        {
            "co_code": 12420,
            "bse_code": 531349,
            "isin": "INE922B01023",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Details Of Shares Dematerialized During March 2025",
            "news_body": "This is to inform that no share has been dematerialised during the month March 2025. \r\n\r\nA copy of certificate obtained from the Companys RTA regarding number of shares dematerialised as on 31.03.2025 is enclosed herewith.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=48f97ce1-fc27-47eb-af26-f2c23ab1d70a.pdf",
            "news_date": "2025-04-07 16:34:09"
        },
        {
            "co_code": 12420,
            "bse_code": 531349,
            "isin": "INE922B01023",
            "ann_type": "General_Announcements",
            "descriptor": "Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "news_body": "We are enclosing herewith a certificate dated April 02 2025 issued by Skyline Financial Services Private Limited Registrar and Transfer Agent of the Company confirming compliance under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations 2018 for the quarter ended March 31 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fed0c2a7-9841-441f-a68e-3f148767ff0e.pdf",
            "news_date": "2025-04-03 16:06:41"
        },
        {
            "co_code": 12420,
            "bse_code": 531349,
            "isin": "INE922B01023",
            "ann_type": "General_Announcements",
            "descriptor": "Change in Management",
            "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
            "news_body": "We would like to inform you that Mr. Sunil Anand Associate Director - Finance & Corporate Affairs of the Company designated as Senior Management Personnel has superannuated from the services of the Company on March 31 2025. Consequently he ceased to be Senior Management Personnel of the Company on March 31 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2616995a-3bbe-4f30-bd6e-defebd71d75b.pdf",
            "news_date": "2025-04-01 09:49:02"
        },
        {
            "co_code": 12420,
            "bse_code": 531349,
            "isin": "INE922B01023",
            "ann_type": "General_Announcements",
            "descriptor": "Change in Directorate",
            "caption": "Announcement under Regulation 30 (LODR)-Change in Directorate",
            "news_body": "We would like to inform you that Mr. Narotam Kumar Juneja non-executive non independent director of the Company was re-appointed as director liable to retire by rotation in the AGM held on 27.09.2024 for a period upto 31.03.2025. Accordingly he has completed his tenure as non-executive non-independent director and consequently ceased to be director of the Company on 31.03.2025.\r\n\r\nSimilarly he has also completed his tenure as Whole-time Director in the Companys material subsidiary Panacea Biotec Pharma Ltd. on 31.03.2025.\r\n\r\nThe details as required under SEBI Circular dated 13.07.2023 are attached herewith.\r\n\r\n",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5ac6f6e4-e337-4907-89c6-1ae2dbe82c41.pdf",
            "news_date": "2025-04-01 09:30:54"
        },
        {
            "co_code": 12420,
            "bse_code": 531349,
            "isin": "INE922B01023",
            "ann_type": "Outcome",
            "descriptor": "Postal Ballot",
            "caption": " Shareholder Meeting / Postal Ballot-Scrutinizer\"s Report",
            "news_body": "We would like to inform you that as per the Scrutinizers Report all the resolutions mentioned in the Postal ballot notice dated February 14 2025 have been passed by the shareholders with requisite majority.\r\n\r\nThe detailed voting results along with the Scrutinizers Report are attached herewith.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=33da8627-6866-4d9f-a184-c87c42b6f481.pdf",
            "news_date": "2025-03-31 19:56:16"
        },
        {
            "co_code": 12420,
            "bse_code": 531349,
            "isin": "INE922B01023",
            "ann_type": "Outcome",
            "descriptor": "Postal Ballot",
            "caption": "Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot",
            "news_body": "We would like to inform you that as per the Scrutinizers Report all the resolutions mentioned in the Postal Ballot notice dated February 14 2025 have been passed by the shareholders with requisite majority.\r\n\r\nThe detailed voting results along with Scrutinizers Report are attached herewith.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cb6bda72-d39b-4434-8813-19294e468ba2.pdf",
            "news_date": "2025-03-31 19:51:10"
        },
        {
            "co_code": 12420,
            "bse_code": 531349,
            "isin": "INE922B01023",
            "ann_type": "General_Announcements",
            "descriptor": "Change in Directorate",
            "caption": "Announcement under Regulation 30 (LODR)-Change in Directorate",
            "news_body": "We would like to inform you that Mrs. Manjula Upadhyay Independent Director of the Company has completed her second and final term of 5 consecutive years as Independent Director on March 29 2025 and consequently she has ceased to be the director of the Company. \r\n\r\nThe details required to be disclosed as per SEBI Circular dated July 13 2023 are attached herewith.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4e04f6f8-2f38-471d-898b-f3622a118d6d.pdf",
            "news_date": "2025-03-30 08:09:31"
        },
        {
            "co_code": 12420,
            "bse_code": 531349,
            "isin": "INE922B01023",
            "ann_type": "Intimation",
            "descriptor": "Closure of Trading Window",
            "caption": "Closure of Trading Window",
            "news_body": "We would like to inform you that the trading window of the Company shall remain closed for all the Designated Persons and Insiders (including their immediate relatives) of the Company from April 01 2025 till completion of 48 hours from the announcement of the Audited Financial Results of the Company for the quarter and financial year ending March 31 2025 to the Stock Exchanges.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9bf714e7-a24b-4e39-adb6-90345449b0de.pdf",
            "news_date": "2025-03-26 15:00:00"
        },
        {
            "co_code": 12420,
            "bse_code": 531349,
            "isin": "INE922B01023",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Clarification On Movement In Price",
            "news_body": "Please find attached Companys response dated March 12 2025 on Clarification in Price Movement.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c9fe2ca1-d342-4b58-8ca2-c40bc1135f5e.pdf",
            "news_date": "2025-03-12 10:17:31"
        },
        {
            "co_code": 12420,
            "bse_code": 531349,
            "isin": "INE922B01023",
            "ann_type": "General",
            "descriptor": "Clarification",
            "caption": "Clarification sought from Panacea Biotec Ltd",
            "news_body": "The Exchange has sought clarification from Panacea Biotec Ltd on March 11 2025 with reference to significant movement in price in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded.<BR><BR>The reply is awaited.",
            "file_url": "",
            "news_date": "2025-03-11 18:25:30"
        },
        {
            "co_code": 12420,
            "bse_code": 531349,
            "isin": "INE922B01023",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Demat Report For The Month Of February 2025",
            "news_body": "Please find enclosed herewith the details of shares dematerialized during February 2025 under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations 2018",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6492eb6a-16d4-4fe9-845f-5ee899494998.pdf",
            "news_date": "2025-03-04 17:23:50"
        },
        {
            "co_code": 12420,
            "bse_code": 531349,
            "isin": "INE922B01023",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Please find enclosed newspaper copies of the Postal Ballot Notice and Remote e-voting information published in the newspapers on February 28 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a0a25878-bb30-49a0-baf8-788df7db40fd.pdf",
            "news_date": "2025-02-28 17:32:45"
        },
        {
            "co_code": 12420,
            "bse_code": 531349,
            "isin": "INE922B01023",
            "ann_type": "Intimation",
            "descriptor": "Postal Ballot",
            "caption": "Shareholder Meeting / Postal Ballot-Notice of Postal Ballot",
            "news_body": "Please find attached a copy of the Postal Ballot Notice dated February 14 2025 along with Annexures thereto being sent to the shareholders through email only for the purpose of obtaining their approval on the Resolutions as mentioned in the said Notice.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f323ad9c-d120-4f59-8fc7-d1a7edfaf06e.pdf",
            "news_date": "2025-02-27 16:26:58"
        },
        {
            "co_code": 12420,
            "bse_code": 531349,
            "isin": "INE922B01023",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Please find enclosed herewith newspaper copies of the Extract of Statement of Unaudited Standalone and Consolidated Financial Results for the quarter and nine months ended December 31 2024.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3fdb32cc-8860-42c9-9f17-9719024c4dd3.pdf",
            "news_date": "2025-02-15 13:59:00"
        },
        {
            "co_code": 12420,
            "bse_code": 531349,
            "isin": "INE922B01023",
            "ann_type": "General_Announcements",
            "descriptor": "Change in Directorate",
            "caption": "Announcement under Regulation 30 (LODR)-Change in Directorate",
            "news_body": "Please find attached disclosure regarding appointment / re-appointment of Directors",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f081c457-96d7-4815-b81f-e74c7363cccc.pdf",
            "news_date": "2025-02-15 00:12:20"
        },
        {
            "co_code": 12420,
            "bse_code": 531349,
            "isin": "INE922B01023",
            "ann_type": "General_Announcements",
            "descriptor": "Integrated Filing (Financial)",
            "caption": "Integrated Filing (Financial)",
            "news_body": "Integrated Filing (Financial) for the quarter ended December 31 2024.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a3c943fa-c891-4d0f-ad55-0ff86d8ea146.pdf",
            "news_date": "2025-02-14 19:40:10"
        },
        {
            "co_code": 12420,
            "bse_code": 531349,
            "isin": "INE922B01023",
            "ann_type": "General_Announcements",
            "descriptor": "Change in Management",
            "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
            "news_body": "Please find attached disclosures regarding appointment / re-appointment of directors and change in Senior Management Personnel",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1572d290-8fbb-4dc6-a8fa-b65127338d87.pdf",
            "news_date": "2025-02-14 18:49:04"
        },
        {
            "sym": "PANACEABIO",
            "disp": "Panacea Biotec",
            "bse_code": 531349,
            "isin": "INE922B01023",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Standalone And Consolidated Unaudited Financial Results (Provisional) Along With Limited Review Report For The Quarter And Nine Months Ended December 31 2024",
            "news_body": "The Board of Directors in its meeting held today i.e. 14.02.2025 inter-alia considered and approved the unaudited Standalone and Consolidated Financial Results of the Company for quarter and nine months ended December 31 2024.\r\n\r\nThe said results are enclosed herewith as annexure.",
            "news_id": "3e3e818c-5f12-4446-86be-b8e33e6b82b1",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c6930f3c-9142-4881-8bfb-97a1ef113ac7.pdf",
            "news_date": "2025-02-14 18:42:40",
            "seo": "panacea-biotec-ltd",
            "ltp": 354.6,
            "ch": -19.849999999999966,
            "pch": -5.301108292161828,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4055,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 12420,
            "bse_code": 531349,
            "isin": "INE922B01023",
            "ann_type": "Outcome",
            "descriptor": "Financial Results",
            "caption": "Standalone And Consolidated Unaudited Financial Results (Provisional) Along With Limited Review Report For The Quarter And Nine Months Ended December 31 2024",
            "news_body": "The Board of Directors in its meeting held today i.e. 14.02.2025 inter-alia considered and approved the unaudited Standalone and Consolidated Financial Results of the Company for quarter and nine months ended December 31 2024.\r\n\r\nThe said results are enclosed herewith as annexure.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c6930f3c-9142-4881-8bfb-97a1ef113ac7.pdf",
            "news_date": "2025-02-14 18:42:40"
        },
        {
            "co_code": 12420,
            "bse_code": 531349,
            "isin": "INE922B01023",
            "ann_type": "Outcome",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for 1. Unaudited Financial Results For The Quarter And Nine Months Ended 31.12.2024\r\n2. Appointment / Re-Appointment Of Directors\r\n3. Change In Senior Management Personnel\r\n4. Re",
            "news_body": "Please find attached outcome of the Board Meeting of Panacea Biotec Limited held on February 14 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=34b70895-3ecb-4f64-a698-a09bbad8ab8b.pdf",
            "news_date": "2025-02-14 18:32:06"
        },
        {
            "co_code": 12420,
            "bse_code": 531349,
            "isin": "INE922B01023",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015",
            "news_body": "The Board of Directors of the Companys material subsidiary Panacea Biotec Pharma Limited (\"PBPL\") has in its meeting held on 13.02.2025 appointed Dr. Sanjay Trehan as Whole-time Director for a term of 3 years w.e.f. 13.02.2025.\r\n\r\nWe would also like to inform the change in Senior Management Personnel of PBPL due to change in internal role responsibilities and reporting structure. \r\n\r\nThe details pursuant to the SEBI Circular dated 13.07.2023 is attached herewith.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=18db9b44-6e67-4d6c-8569-369ee44e62a7.pdf",
            "news_date": "2025-02-13 17:19:20"
        },
        {
            "co_code": 12420,
            "bse_code": 531349,
            "isin": "INE922B01023",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Demat Report For The Month Of January 2025",
            "news_body": "Please find attached the details of shares dematerialised during January 2025 under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations 2018",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3753613b-51db-4632-8a76-06ec16c4f0eb.pdf",
            "news_date": "2025-02-07 15:49:43"
        },
        {
            "co_code": 12420,
            "bse_code": 531349,
            "isin": "INE922B01023",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Approval Of  Standalone And Consolidated Unaudited Financial Results (Provisional) For The Quarter And Nine Months Ended December 31 2024",
            "news_body": "PANACEA BIOTEC LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2025 inter alia to consider and approve Standalone and Consolidated Unaudited Financial Results (Provisional) for the quarter and nine months ended December 31 2024.\r\n\r\nThe trading window of the Company shall remain closed for all Designated Persons till February 16 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=84b213b6-9da6-426f-96ec-2f569fc99c81.pdf",
            "news_date": "2025-01-31 14:40:35"
        },
        {
            "co_code": 12420,
            "bse_code": 531349,
            "isin": "INE922B01023",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 (SEBI LODR Regulations)",
            "news_body": "In continuation to our earlier communication dated 20.08.2024 regarding receipt of demand order we are pleased to inform you that the Honble Bombay High Court has set aside the demand order on 22.01.2025 and the matter has been remanded back to Assistant Commissioner of Sales Tax Mumbai for a fresh adjudication on the show cause notice.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c18321db-6e74-4576-b4d2-178a12ca569f.pdf",
            "news_date": "2025-01-23 15:18:52"
        },
        {
            "co_code": 12420,
            "bse_code": 531349,
            "isin": "INE922B01023",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Details Of Shares Dematerialized During December 2024",
            "news_body": "This is to inform that no share has been dematerialized during December 2024. \n\nA certificate received from RTA in this regard is also enclosed herewith alongwith demat status report for December 2024",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=02506821-4e81-48dc-bf17-3643b2a4707f.pdf",
            "news_date": "2025-01-07 16:53:31"
        },
        {
            "co_code": 12420,
            "bse_code": 531349,
            "isin": "INE922B01023",
            "ann_type": "General_Announcements",
            "descriptor": "Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "news_body": "Please find attached herewith the compliance certificate under Regulation 74(5) of SEBI (Depositories and Participant) Regulations 2018 for quarter ended December 31 2024",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d76d690d-8368-4b5e-bc57-94285542d02f.pdf",
            "news_date": "2025-01-07 15:08:07"
        },
        {
            "co_code": 12420,
            "bse_code": 531349,
            "isin": "INE922B01023",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Intimation Regarding Launch Of Baby Diapers And Wipes By CompanyS Wholly-Owned Subsidiary Panacea Biotec Pharma Limited",
            "news_body": "We are pleased to announce that the Companys wholly owned subsidiary Panacea Biotec Pharma Limited (\"PBPL\") has launched baby diapers and wipes under the brand name \" NikoMom\".\n\nThe details of the said product pursuant to SEBI Circular dated July 13 2023 is attached herewith",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=27c212ce-eb01-455e-960f-5f14fc1d5619.pdf",
            "news_date": "2025-01-03 15:05:17"
        },
        {
            "co_code": 12420,
            "bse_code": 531349,
            "isin": "INE922B01023",
            "ann_type": "General_Announcements",
            "descriptor": "Change in Management",
            "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
            "news_body": "In continuation to our letter dated 09.12.2024 we would like to inform you that Mr. Rajesh Kumar Vice President - Manufacturing Excellence of the Company has now been relieved from his duties with effect from close of business hours on December 31 2024 at 05:45 P.M.\n\nThe detailed disclosure under SEBI Circular dated 13.07.2023 is attached herewith.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4b138f67-4774-4c66-af68-6241801ceaf4.pdf",
            "news_date": "2025-01-01 11:23:50"
        },
        {
            "co_code": 12420,
            "bse_code": 531349,
            "isin": "INE922B01023",
            "ann_type": "Outcome",
            "descriptor": "Postal Ballot",
            "caption": " Shareholder Meeting / Postal Ballot-Scrutinizer\"s Report",
            "news_body": "We would like to inform you that as per the Scrutinizers Report all the resolutions mentioned in the Postal Ballot Notice dated 13.11.2024 have been passed by the shareholders with requisite majority.\n\nPursuant to Regulation 44(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 the detailed voting results along with the Scrutinizers Report are attached herewith.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fa7fe209-47ad-4921-b2fc-1ecb5bf7e85a.pdf",
            "news_date": "2024-12-28 16:42:44"
        },
        {
            "sym": "PANACEABIO",
            "disp": "Panacea Biotec",
            "bse_code": 531349,
            "isin": "INE922B01023",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Standalone And Consolidated Unaudited Financial Results (Provisional) Along With Limited Review Report For The Quarter And Half Year Ended September 30, 2024",
            "news_body": "Please find attached Standalone and Consolidated Unaudited Financial Results (Provisional) for quarter and half year ended September 30, 2024",
            "news_id": "837d5164-fe8a-4a53-b144-416b8186a8a5",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=673fc0ef-0ffd-4bb8-94c3-10df0ee870e3.pdf",
            "news_date": "2024-11-13 15:51:30",
            "seo": "panacea-biotec-ltd",
            "ltp": 354.6,
            "ch": -19.849999999999966,
            "pch": -5.301108292161828,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4055,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "PANACEABIO",
            "disp": "Panacea Biotec",
            "bse_code": 531349,
            "isin": "INE922B01023",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Standalone And Consolidated Unaudited Financial Results (Provisional) Along With Limited Review Report For The Quarter Ended 30.06.2024",
            "news_body": "Please find attached Standalone and Consolidated Unaudited Financial Results for the quarter ended June 30, 2024 along with Limited Review Report",
            "news_id": "d7305297-860b-4795-9a6b-1d97274eaba4",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=103231a5-6a34-4ed3-9ba5-aa26766593e5.pdf",
            "news_date": "2024-08-14 16:25:20",
            "seo": "panacea-biotec-ltd",
            "ltp": 354.6,
            "ch": -19.849999999999966,
            "pch": -5.301108292161828,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4055,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "PANACEABIO",
            "disp": "Panacea Biotec",
            "bse_code": 531349,
            "isin": "INE922B01023",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Standalone And Consolidated Audited Financial Results Of The Company For The Quarter And Financial Year Ended March 31, 2024",
            "news_body": "The Board of Directors in its meeting held on May 30, 2024 approved the Standalone and Consolidated Audited Financial Results of the Company for the quarter and financial year ended March 31, 2024",
            "news_id": "b475646d-1855-4dac-bb76-b1c69e9bfc95",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=64585325-909c-468f-b4f3-8f447ed63d93.pdf",
            "news_date": "2024-05-30 14:22:40",
            "seo": "panacea-biotec-ltd",
            "ltp": 354.6,
            "ch": -19.849999999999966,
            "pch": -5.301108292161828,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4055,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "PANACEABIO",
            "disp": "Panacea Biotec",
            "bse_code": 531349,
            "isin": "INE922B01023",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Standalone And Consolidated Unaudited Financial Results (Provisional) Along With Limited Review Report For The Quarter And Nine Months Ended December 31, 2023",
            "news_body": "Unaudited financial results for quarter and nine months ended December 31, 2023 are enclosed herewith as Annexure -A",
            "news_id": "e54875ed-a6bd-4503-9095-11cebc15a74b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=50d676c4-86be-4322-8347-8b6716280bad.pdf",
            "news_date": "2024-02-13 14:50:02",
            "seo": "panacea-biotec-ltd",
            "ltp": 354.6,
            "ch": -19.849999999999966,
            "pch": -5.301108292161828,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4055,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "PANACEABIO",
            "disp": "Panacea Biotec",
            "bse_code": 531349,
            "isin": "INE922B01023",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Standalone And Consolidated Unaudited Financial Results (Provisional) Along With Limited Review Report For The Quarter And Half Year Ended September 30, 2023",
            "news_body": "Please find enclosed herewith the Unaudited Standalone and Consolidated Financial results (Provisional) of the Company for quarter and half year ended September 30, 2023, as approved by the Board of Directors in its meeting held today i.e. November 10, 2023",
            "news_id": "e04884b8-648b-4e7d-bc2e-51c4f01de349",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=524de7f4-25f9-4886-b960-51e4320816b8.pdf",
            "news_date": "2023-11-10 13:44:48",
            "seo": "panacea-biotec-ltd",
            "ltp": 354.6,
            "ch": -19.849999999999966,
            "pch": -5.301108292161828,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4055,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "PANACEABIO",
            "disp": "Panacea Biotec",
            "bse_code": 531349,
            "isin": "INE922B01023",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Standalone And Consolidated Financial Results (Provisional) Of The Company For The Quarter Ended June 30, 2023",
            "news_body": "The Board of Directors in its meeting held on August 12, 2023, has considered and approved Unaudited Standalone and Consolidated Financial Results for the quarter ended June 30, 2023.<BR> <BR> The meeting of the Board commenced at 11:30 A.M. and concluded at 3:00 P.M.",
            "news_id": "686d8690-6ffc-4af0-b99a-207c4d364ae7",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=29959a98-0be7-43a9-96f3-6e917fa8ef0c.pdf",
            "news_date": "2023-08-12 15:17:47",
            "seo": "panacea-biotec-ltd",
            "ltp": 354.6,
            "ch": -19.849999999999966,
            "pch": -5.301108292161828,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4055,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "PANACEABIO",
            "disp": "Panacea Biotec",
            "bse_code": 531349,
            "isin": "INE922B01023",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Standalone And Consolidated Audited Financial Results Of The Company For The Quarter And Financial Year Ended March 31, 2023",
            "news_body": "The Board of Directors of the Company has, at its meeting held today, i.e. May 30, 2023, inter-alia, considered and approved the Standalone and Consolidated Audited Financial Results of the Company for the Quarter and Financial Year ended March 31, 2023. The same were also reviewed by the Audit Committee in its meeting held on May 29, 2023.A copy of the same along with the Auditors' Report is enclosed herewith as Annexure - A.The meeting of the Board of Directors commenced at 11:00 A.M. and concluded at 2:30 P.M.",
            "news_id": "00dd74a7-4c60-48a1-b394-d99a93ed2b10",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d1aaf66d-aadc-4b62-a41e-7c0ea3a8eb6a.pdf",
            "news_date": "2023-05-30 14:53:02",
            "seo": "panacea-biotec-ltd",
            "ltp": 354.6,
            "ch": -19.849999999999966,
            "pch": -5.301108292161828,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4055,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "PANACEABIO",
            "disp": "Panacea Biotec",
            "bse_code": 531349,
            "isin": "INE922B01023",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Revised Standalone And Consolidated Unaudited Financial Results (Provisional) Along With Limited Review Report For The Quarter And Nine Months Ended December 31, 2022",
            "news_body": "In continuation to our letter dated February 14, 2023, we would like to inform you that we have noted that due to inadvertent typographical/clerical error, the consolidated figures for Depreciation and amortisation expenses and Finance costs for the nine months ended December 31, 2022 as mentioned in the Statement of Standalone and Consolidated Financial Results (Unaudited) for the quarter and nine months ended December 31, 2022 were replaced with each other as a result of which the consolidated figures for these items for the quarter and nine months ended December 31, 2022 got mentioned incorrect.",
            "news_id": "f0f73065-e112-4abc-be38-4f5644dc210b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ae927907-d42f-49ed-9f68-6640b6abd161.pdf",
            "news_date": "2023-02-15 14:38:09",
            "seo": "panacea-biotec-ltd",
            "ltp": 354.6,
            "ch": -19.849999999999966,
            "pch": -5.301108292161828,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4055,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "PANACEABIO",
            "disp": "Panacea Biotec",
            "bse_code": 531349,
            "isin": "INE922B01023",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Standalone And Consolidated Unaudited Financial Results (Provisional) Along With Limited Review Report For The Quarter And Nine Months Ended December 31, 2022",
            "news_body": "We would like to inform you that the Board of Directors of the Company has, at its meeting held today, i.e. February 14, 2023, inter-alia, considered and approved the Unaudited Standalone and Consolidated Financial Results (Provisional) of the Company (which have been subjected to Limited Review by the Statutory Auditors) for the quarter and nine months ended December 31, 2022.<BR> The same were also reviewed by the Audit Committee in its meeting held on February 13, 2023. A copy of the same along with the Limited Review Report is enclosed herewith as Annexure - A. <BR> The Board Meeting commenced at 10:30 A.M. and concluded at 1:15 P.M.<BR> We request you to kindly bring the above information to the notice of your members.<BR> <BR>",
            "news_id": "9bc70dab-068f-474e-ab8f-e418cfe2c0e2",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1cd6d72b-1e2a-482d-af2a-7f39e74704ae.pdf",
            "news_date": "2023-02-14 13:43:08",
            "seo": "panacea-biotec-ltd",
            "ltp": 354.6,
            "ch": -19.849999999999966,
            "pch": -5.301108292161828,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4055,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "PANACEABIO",
            "disp": "Panacea Biotec",
            "bse_code": 531349,
            "isin": "INE922B01023",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Disclosure Of Related Party Transactions Under Regulation 23(9) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015",
            "news_body": "Pursuant to Regulation 23(9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Circular no. SEBI/HO/CFO/CMD1/CIR/P/2021/662 dated November 22, 2021, please find enclosed disclosure of related party transactions for half year ended September 30, 2022. This is for your kind information and record please.",
            "news_id": "3d7589ac-67dd-4950-800a-6d87b260bbe8",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c1a4d60e-c3e8-4ca3-a683-f252b155dc11.pdf",
            "news_date": "2022-11-29 14:59:09",
            "seo": "panacea-biotec-ltd",
            "ltp": 354.6,
            "ch": -19.849999999999966,
            "pch": -5.301108292161828,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4055,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "PANACEABIO",
            "disp": "Panacea Biotec",
            "bse_code": 531349,
            "isin": "INE922B01023",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Standalone And Consolidated Unaudited Financial Results (Provisional) Along With Limited Review Report For The Quarter And Half Year Ended September 30, 2022",
            "news_body": "We would like to inform you that Board of Directors of the Company has, at its meeting held today, i.e. 14.11.2022, inter-alia, considered and approved the Unaudited Standalone and Consolidated Financial Results (Provisional) of the Company (which have been subjected to Limited Review by the Statutory Auditors) for the quarter and half year ended 30.09.2022. The same were also reviewed by the Audit Committee in its meeting held earlier on 14.11.2022. A copy of the same along with the Limited Review Report is enclosed herewith as Annexure - A. <BR> <BR> We wish to further inform you that the Board of Directors has also decided the elevation of Dr. Rajesh Jain, Managing Director to the position of Chairman & Managing Director of the Company.<BR> <BR> The meeting of the Board of Directors commenced at 02:30 P.M. and concluded at 4:40 P.M. <BR> <BR> We request you to kindly bring the above information to the notice of your members.<BR>",
            "news_id": "e1ea7524-d1b5-455f-825e-ab6b131a4fe9",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=83b5bee2-094a-485d-8d8d-2caa311d5e51.pdf",
            "news_date": "2022-11-14 16:54:18",
            "seo": "panacea-biotec-ltd",
            "ltp": 354.6,
            "ch": -19.849999999999966,
            "pch": -5.301108292161828,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4055,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "PANACEABIO",
            "disp": "Panacea Biotec",
            "bse_code": 531349,
            "isin": "INE922B01023",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Standalone And Consolidated Unaudited Financial Results (Provisional) Along With Limited Review Report For The Quarter Ended June 30, 2022",
            "news_body": "The Board of Directors of the Company has, at its meeting held today, i.e. August 09, 2022, inter-alia, considered and approved the Unaudited Standalone and Consolidated Financial Results (Provisional) of the Company (which have been subjected to Limited Review by the Statutory Auditors) for the quarter ended June 30, 2022. The same were also reviewed by the Audit Committee in its meeting held earlier on August 09, 2022.<BR> <BR> A copy of the same along with the Limited Review Report is enclosed herewith as Annexure - A.<BR> <BR> The meeting of the Board of Directors commenced at 12:30 P.M. and concluded at 3:15 P.M.",
            "news_id": "f648e9d0-30e8-42b9-a796-0a0d55fc584b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=eae1450a-4de7-4de4-b19d-e3fb49e4c99c.pdf",
            "news_date": "2022-08-09 15:30:38",
            "seo": "panacea-biotec-ltd",
            "ltp": 354.6,
            "ch": -19.849999999999966,
            "pch": -5.301108292161828,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4055,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "PANACEABIO",
            "disp": "Panacea Biotec",
            "bse_code": 531349,
            "isin": "INE922B01023",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for  I.  Standalone And Consolidated Unaudited Financial Results (Provisional) Along With Limited Review Report For The Quarter Ended June 30, 2022<BR> Ii. Date, Time And Venue Of The 38Th AGM <BR>  Iii. Dates Of Book Closure",
            "news_body": "The Board of Directors of the Company has, at its meeting held on 09.08.2022, inter-alia, considered and approved the Unaudited Standalone and Consolidated Financial Results (Provisional) for the quarter ended June 30, 2022. The same were also reviewed by the Audit Committee in its meeting held earlier on 09.08.2022.<BR> <BR> We wish to further inform you that the Board of Directors has also decided that:<BR> <BR> i) the 38th AGM of the Company will be held on Wednesday, 28.09.2022 at 11:30 A.M. through VC / Other Audio-Visual Means; and <BR> ii) the Register of Members and Share Transfer Books will remain closed from Wednesday, 21.09.2022 to Wednesday, 28.09.2022 (both days inclusive) for the purpose of AGM. <BR> <BR> The meeting of the Board of Directors commenced at 12:30 P.M. and concluded at 3:15 P.M.<BR>",
            "news_id": "07af3986-9634-4b61-8995-9d5d9317774a",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b7a61069-a9f3-41f2-b5c5-4e72c36a9ccf.pdf",
            "news_date": "2022-08-09 15:26:05",
            "seo": "panacea-biotec-ltd",
            "ltp": 354.6,
            "ch": -19.849999999999966,
            "pch": -5.301108292161828,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4055,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "PANACEABIO",
            "disp": "Panacea Biotec",
            "bse_code": 531349,
            "isin": "INE922B01023",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Standalone And Consolidated Audited Financial Results Of The Company For The Quarter And Financial Year Ended March 31, 2022",
            "news_body": "We would like to inform you that the Board of Directors of the Company has, at its meeting held today, i.e. May 18, 2022, inter-alia, considered and approved the following:-<BR> a. Standalone and Consolidated Audited Financial Results of the Company for the Quarter and Financial Year ended March 31, 2022. The same were also reviewed by the Audit Committee in its meeting held earlier on May 18, 2022. A copy of the same along with the Auditors' Report is enclosed herewith as Annexure - A. <BR> b. Seeking shareholders' approval through Postal Ballot for :<BR>   Appointment of Mr. Narotam Kumar Juneja (DIN: 01204817) as a Non-Executive Non-Independent Director; <BR>   Adoption of new set of Articles of Association of Company; and<BR>   Granting of loans, guarantees etc. and investment by way of acquisition of securities of any other bodies corporate & mutual funds etc. <BR> <BR> The meeting of the Board of Directors commenced at 12:30 P.M. and concluded at 2:40 P.M.<BR>",
            "news_id": "201abafd-25f3-4696-aa82-083926802013",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4bea835e-99a6-4cba-8250-5f387fcf89d0.pdf",
            "news_date": "2022-05-18 15:01:11",
            "seo": "panacea-biotec-ltd",
            "ltp": 354.6,
            "ch": -19.849999999999966,
            "pch": -5.301108292161828,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4055,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "PANACEABIO",
            "disp": "Panacea Biotec",
            "bse_code": 531349,
            "isin": "INE922B01023",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting",
            "news_body": "We would like to inform you that the Board of Directors of the Company has, at its meeting held today, i.e. May 18, 2022, inter-alia, considered and approved the following:-<BR> <BR> a. Standalone and Consolidated Audited Financial Results of the Company for the Quarter and Financial Year ended March 31, 2022. The same were also reviewed by the Audit Committee in its meeting held earlier on May 18, 2022. A copy of the same along with the Auditors' Report is enclosed herewith as Annexure - A. <BR> b. Seeking shareholders' approval through Postal Ballot for :<BR>   Appointment of Mr. Narotam Kumar Juneja (DIN: 01204817) as a Non-Executive Non-Independent Director; <BR>   Adoption of new set of Articles of Association of Company; and<BR>   Granting of loans, guarantees etc. and investment by way of acquisition of securities of any other bodies corporate & mutual funds etc. <BR> <BR> The meeting of the Board of Directors commenced at 12:30 P.M. and concluded at 2:40 P.M.<BR>",
            "news_id": "9fce5823-d847-4259-adb6-af1b1dda922a",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b21bf3ba-e7d9-48d1-b649-0529b952d6c0.pdf",
            "news_date": "2022-05-18 14:53:29",
            "seo": "panacea-biotec-ltd",
            "ltp": 354.6,
            "ch": -19.849999999999966,
            "pch": -5.301108292161828,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4055,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "PANACEABIO",
            "disp": "Panacea Biotec",
            "bse_code": 531349,
            "isin": "INE922B01023",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Standalone And Consolidated Unaudited Financial Results (Provisional) Along With Limited Review Report For The Quarter And Nine Months Ended December 31, 2021",
            "news_body": "We would like to inform you that the Board of Directors of the Company has, at its meeting held today, i.e. February 14, 2022, inter-alia, considered and approved the Unaudited Standalone and Consolidated Financial Results (Provisional) of the Company (which have been subjected to Limited Review by the Statutory Auditors) for the quarter and nine months ended December 31, 2021. <BR> <BR> Pursuant to Regulation 47(1)(b) of SEBI LODR Regulations, the Extract of Statement of above said financial results for the quarter and nine months ended December 31, 2021 in the Format as prescribed in Annexure I of SEBI Circular No. CIR/CFD/FAC/62/2016 dated 05.07.2016 is being sent for publication in newspapers. <BR> <BR> The meeting of the Board of Directors commenced at 02:30 P.M. and concluded at 04:00 P.M. <BR> <BR> We request you to kindly bring the above information to the notice of your members.<BR>",
            "news_id": "4f193c6a-0b51-482d-80a9-66d2dae8f489",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=89d659d5-6178-4e24-bb2e-e182f40dde83.pdf",
            "news_date": "2022-02-14 16:16:03",
            "seo": "panacea-biotec-ltd",
            "ltp": 354.6,
            "ch": -19.849999999999966,
            "pch": -5.301108292161828,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4055,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "PANACEABIO",
            "disp": "Panacea Biotec",
            "bse_code": 531349,
            "isin": "INE922B01023",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Standalone And Consolidated Unaudited Financial Results (Provisional) Along With Limited Review Report For The Quarter And Half Year Ended September 30, 2021",
            "news_body": "In continuation to our letter dated November 02, 2021 and pursuant to Regulations 30 and 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the Board of Directors of the Company has, at its meeting held today, i.e. November 12, 2021, inter-alia, considered and approved the Unaudited Standalone and Consolidated Financial Results (Provisional) of the Company (which have been subjected to Limited Review by the Statutory Auditors) for the quarter and half year ended September 30, 2021. The same were also reviewed by the Audit Committee in its meeting held earlier on November 12, 2021.<BR> The meeting of the Board of Directors commenced at 02:30 P.M. and concluded at 05:15 P.M. <BR> We request you to kindly bring the above information to the notice of your members.<BR>",
            "news_id": "d4c2aa1a-a160-4062-926f-c7b19a56e045",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7d0ede7d-0a0a-4ccd-a32e-0b060dd5f053.pdf",
            "news_date": "2021-11-12 17:40:23",
            "seo": "panacea-biotec-ltd",
            "ltp": 354.6,
            "ch": -19.849999999999966,
            "pch": -5.301108292161828,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4055,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "PANACEABIO",
            "disp": "Panacea Biotec",
            "bse_code": 531349,
            "isin": "INE922B01023",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "In continuation to our letter dated July 28, 2021 and in compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the revised Investor Presentation uploaded on the website of the Company at the link: https://www.panaceabiotec.com/comorate-presentation.<BR> The Company will now use this presentation for meetings with analysts / institutional investors.<BR> <BR> This is for your kind information and record please.",
            "news_id": "b5a82d7d-bd0d-4a39-860f-3c3ec9f902ba",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2cee182a-92e6-42da-8a95-a26a9fd929bf.pdf",
            "news_date": "2021-08-02 11:08:32",
            "seo": "panacea-biotec-ltd",
            "ltp": 354.6,
            "ch": -19.849999999999966,
            "pch": -5.301108292161828,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4055,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "PANACEABIO",
            "disp": "Panacea Biotec",
            "bse_code": 531349,
            "isin": "INE922B01023",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "In compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the Investor Presentation uploaded on the website of the Company at the link: https://www.panaceabiotec.com/corporate-presentation.<BR> <BR> The Company will use this presentation for meetings with analysts / institutional investors.<BR> <BR> This is for your kind information and record please.",
            "news_id": "70e7c182-a35c-4104-bb9b-951136ff2181",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ec4d923a-0b87-44b8-b2af-7f0341872c97.pdf",
            "news_date": "2021-07-28 14:00:34",
            "seo": "panacea-biotec-ltd",
            "ltp": 354.6,
            "ch": -19.849999999999966,
            "pch": -5.301108292161828,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4055,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "PANACEABIO",
            "disp": "Panacea Biotec",
            "bse_code": 531349,
            "isin": "INE922B01023",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Standalone And Consolidated Unaudited Financial Results (Provisional) Along With Limited Review Report For The Quarter Ended June 30, 2021",
            "news_body": "In continuation to our letter dated July 15, 2021 and pursuant to Regulations 30 and 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('SEBI LODR Regulations'), we would like to inform you that the Board of Directors of the Company has, at its meeting held today, i.e. July 23, 2021, inter-alia, considered and approved the Unaudited Standalone and Consolidated Financial Results (Provisional) of the Company (which have been subjected to Limited Review by the Statutory Auditors) for the quarter ended June 30, 2021. The same were also reviewed by the Audit Committee in its meeting held earlier on July 23, 2021.<BR> The meeting of the Board of Directors commenced at 02:30 P.M. and concluded at 4:00 P.M.<BR> We request you to kindly bring the above information to the notice of your members.<BR>",
            "news_id": "7c893f2d-86a1-4866-bb92-e0a096e78dde",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=282fd850-59d7-47f9-ab4e-7630dfd096db.pdf",
            "news_date": "2021-07-23 16:17:02",
            "seo": "panacea-biotec-ltd",
            "ltp": 354.6,
            "ch": -19.849999999999966,
            "pch": -5.301108292161828,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4055,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "PANACEABIO",
            "disp": "Panacea Biotec",
            "bse_code": 531349,
            "isin": "INE922B01023",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of Board Meeting",
            "news_body": "We would like to inform you that the Board of Directors of the Company has, at its meeting held 23.07.2021, inter-alia, considered and approved the Unaudited Standalone and Consolidated Financial Results (Provisional) of the Company (which have been subjected to Limited Review by the Statutory Auditors) for the quarter ended June 30, 2021. The same were also reviewed by the Audit Committee in its meeting held earlier on July 23, 2021. <BR> We wish to further inform you that the Board of Directors has also decided that:<BR> i) the 37th Annual General Meeting of the Company will be held on Saturday, September 25, 2021 at 11:30 A.M. through Video Conferencing / Other Audio-Visual Means; and <BR> ii) the Register of Members and Share Transfer Books will remain closed from Saturday, September 18, 2021 to Saturday, September 25, 2021 (both days inclusive) for the purpose of Annual General Meeting. <BR> The meeting of the Board of Directors commenced at 02:30 P.M. and concluded at 4:00 P.M<BR>",
            "news_id": "e5f108b1-c364-47b7-bf83-ebb0517830cd",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9bc6945c-3115-4d9b-a5e0-3856010a09fe.pdf",
            "news_date": "2021-07-23 16:11:22",
            "seo": "panacea-biotec-ltd",
            "ltp": 354.6,
            "ch": -19.849999999999966,
            "pch": -5.301108292161828,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4055,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "PANACEABIO",
            "disp": "Panacea Biotec",
            "bse_code": 531349,
            "isin": "INE922B01023",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Financial Results (Standalone And Consolidated) Of The Company For The Quarter And Financial Year Ended March 31, 2021",
            "news_body": "In continuation to our letter dated May 24, 2021 and pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('SEBI LODR Regulations'), we would like to inform you that the Board of Directors of the Company has, at its meeting held today, i.e. June 02, 2021 approved the Audited Financial Results (Standalone and Consolidated) of the Company for the Quarter and Financial Year ended March 31, 2021 in terms of Regulation 33 of SEBI LODR Regulations. <BR> <BR> The same were also reviewed by the Audit Committee in its meeting held earlier on June 02, 2021. A copy of the aforesaid Audited Financial Results (Standalone and Consolidated) along with Auditors' Report is enclosed herewith.",
            "news_id": "75ba61f9-a334-467a-85c4-fba153a7d2ab",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f93ec383-3a82-4cad-be7e-e8c28ea81ba9.pdf",
            "news_date": "2021-06-02 19:32:49",
            "seo": "panacea-biotec-ltd",
            "ltp": 354.6,
            "ch": -19.849999999999966,
            "pch": -5.301108292161828,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4055,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "PANACEABIO",
            "disp": "Panacea Biotec",
            "bse_code": 531349,
            "isin": "INE922B01023",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of Board Meeting",
            "news_body": "We would like to inform you that the Board of Directors of the Company has, at its meeting held today 02.06.2021, inter-alia, considered and approved the following:-<BR> <BR> 1. Audited Financial Results (Standalone and Consolidated) of the Company for the Quarter and Financial Year ended March 31, 2021. The same were also reviewed by the Audit Committee in its meeting held earlier on 02.06.2021. <BR> 2. Raising of funds by the Company through one or more permissible mechanisms as may be deemed appropriate by the Board, for an amount upto and not exceeding INR 12,000 million or its equivalent in any other currency(ies), in one or more tranches, subject to the approval of the Shareholders of the Company and any other regulatory or statutory approvals, as may be required; and<BR> 3. Convening of EGM of the Company on 25.06.2021 at 11:30 A.M. through Video Conferencing / Other Audio-Visual Means.<BR> The meeting of the Board of Directors commenced at 02:00 P.M. and concluded at 07:15 P.M.  <BR>",
            "news_id": "69eab47f-509f-44f8-8e22-c1c4f54415b0",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ee7078ac-fa67-4bb6-abf6-cdf3098d24dc.pdf",
            "news_date": "2021-06-02 19:22:59",
            "seo": "panacea-biotec-ltd",
            "ltp": 354.6,
            "ch": -19.849999999999966,
            "pch": -5.301108292161828,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4055,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "PANACEABIO",
            "disp": "Panacea Biotec",
            "bse_code": 531349,
            "isin": "INE922B01023",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of The Board Meeting",
            "news_body": "Pursuant to Regulations 30 and 33 of SEBI LODR Regulations, we would like to inform you that the Board of Directors of the Company has, at its meeting held today, i.e. February 12, 2021, inter-alia, considered and approved the Unaudited Standalone and Consolidated Financial Results (Provisional) of the Company (which have been subjected to Limited Review by the Statutory Auditors) for the quarter and nine months ended December 31, 2020. The same were also reviewed by the Audit Committee in its meeting held earlier on February 12, 2021. <BR> <BR> Further, pursuant to Regulation 47(1)(b) of SEBI LODR Regulations, the Extract of Statement of above said financial results for the quarter and nine months ended December 31, 2020 in the Format as prescribed in Annexure I of SEBI Circular No. CIR/CFD/FAC/62/2016 dated 05.07.2016 is being sent for publication in newspapers. <BR> <BR> The meeting of the Board of Directors commenced at 02:00 P.M. and concluded at 05:10 P.M<BR>",
            "news_id": "67a5952f-b2f0-4632-a001-ea270d2ac9b7",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d5b6133d-e531-4944-9461-36f9c0ea29ab.pdf",
            "news_date": "2021-02-12 17:31:08",
            "seo": "panacea-biotec-ltd",
            "ltp": 354.6,
            "ch": -19.849999999999966,
            "pch": -5.301108292161828,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4055,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "PANACEABIO",
            "disp": "Panacea Biotec",
            "bse_code": 531349,
            "isin": "INE922B01023",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Standalone And Consolidated Unaudited Financial Results (Provisional) Along With Limited Review Report For The Quarter And Nine Months Ended December 31, 2020",
            "news_body": "Pursuant to Regulations 30 and 33 of SEBI LODR Regulations, we would like to inform you that the Board of Directors of the Company has, at its meeting held today, i.e. February 12, 2021, inter-alia, considered and approved the Unaudited Standalone and Consolidated Financial Results (Provisional) of the Company (which have been subjected to Limited Review by the Statutory Auditors) for the quarter and nine months ended December 31, 2020. The same were also reviewed by the Audit Committee in its meeting held earlier on February 12, 2021. <BR> <BR> Further, pursuant to Regulation 47(1)(b) of SEBI LODR Regulations, the Extract of Statement of above said financial results for the quarter and nine months ended December 31, 2020 in the Format as prescribed in Annexure I of SEBI Circular No. CIR/CFD/FAC/62/2016 dated 05.07.2016 is being sent for publication in newspapers. <BR> <BR> The meeting of the Board of Directors commenced at 02:00 P.M. and concluded at 05:10 P.M<BR>",
            "news_id": "388e63ca-1b31-472c-88b3-f6722ba291b7",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=379ab44a-f680-44a3-bf80-8ed5267c0155.pdf",
            "news_date": "2021-02-12 17:27:55",
            "seo": "panacea-biotec-ltd",
            "ltp": 354.6,
            "ch": -19.849999999999966,
            "pch": -5.301108292161828,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4055,
            "exch": "NSE",
            "seg": "E"
        }
    ]
}